about
Rapamycin versus methotrexate in early diffuse systemic sclerosis: results from a randomized, single-blind pilot study.Endothelin B receptor, a new target in cancer immune therapy.Pulmonary Arterial Hypertension-A Deadly Complication of Systemic Sclerosis.Clinical trials and basic research: defining mechanisms and improving treatment in connective tissue disease.Treatment of diffuse systemic sclerosis with hyperimmune caprine serum (AIMSPRO): a phase II double-blind placebo-controlled trial.Bosentan, an endothelin receptor antagonist, ameliorates collagen-induced arthritis: the role of TNF-α in the induction of endothelin system genes.
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Therapeutic targets in systemic sclerosis.
@en
type
label
Therapeutic targets in systemic sclerosis.
@en
prefLabel
Therapeutic targets in systemic sclerosis.
@en
P2860
P356
P1476
Therapeutic targets in systemic sclerosis.
@en
P2093
Christopher P Denton
P2860
P2888
P356
10.1186/AR2190
P478
P577
2007-01-01T00:00:00Z
P5875
P6179
1051169259